As Celera s CDS Revenues Shrink, Applera Cuts Royalties, Extends Distribution Pact | GenomeWeb

In 2002, Applera assumed that the data held by its Celera Genomics group would produce cash flows of $200 million to $300 million over 10 years and established a royalty plan that would allow its Applied Biosystems group to exclusively market the data until 2012.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.